Placental Passage of Antidepressant Medications
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study determined the placental transfer of antidepressants and their metabolites. METHOD: A total of 38 pregnant women taking citalopram, fluoxetine, paroxetine, or sertraline participated. Maternal and umbilical cord blood samples were obtained to determine antidepressant and metabolite concentrations. RESULTS: Antidepressant and metabolite concentrations were detectable in 86.8% of umbilical cord samples. The mean ratios of umbilical cord to maternal serum concentrations ranged from 0.29 to 0.89. The lowest ratios were for sertraline and paroxetine; the highest were for citalopram and fluoxetine. Maternal doses of sertraline and fluoxetine correlated with umbilical cord concentrations of these medications. CONCLUSIONS: Umbilical cord concentrations of antidepressants and their metabolites were almost invariably lower than corresponding maternal concentrations. Maternal doses predicted umbilical concentrations of fluoxetine and sertraline. Mean umbilical cord to maternal serum ratios were significantly lower for sertraline than fluoxetine, suggesting that sertraline may produce less fetal medication exposure than fluoxetine near delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, J. A., Hamilton, B. E., Ventura, S. J., Menacker, F., & Park, M. M. (2002) · PubMed · Cited by 984
Delivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B., & Wiholm, B.-E. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284
Differential pharmacology of newer antidepressants.
DeVane, C. L. (1998) · PubMed · Cited by 237
Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
Nordeng, H., Lindemann, R., Perminov, K. V., & Reikvam1, Å. (2001) · Acta Paediatrica · doi:10.1080/080352501300067596 · Cited by 181
Birth outcomes following prenatal exposure to fluoxetine
Cohen, L. S., Heller, V. L., Bailey, J. W., Grush, L. R., Ablon, J. S., & Bouffard, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00877-5 · Cited by 137
Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk
Hendrick, V. C., Stowe, Z. N., Altshuler, L. L., Mintz, J., Hwang, S., Hostetter, A. L., Suri, R., Leight, K. L., & Fukuchi, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01197-0 · Cited by 126
Self-citationWeight Gain in Infants Breastfed by Mothers Who Take Fluoxetine
Chambers, C., Anderson, P. O., Thomas, R. G., Dick, L. M., Felix, R. J., Johnson, K. A., & Jones, K. L. (1999) · PEDIATRICS · doi:10.1542/peds.104.5.e61 · Cited by 107
Neonatal apnea associated with maternal clonazepam therapy: a case report.
Fisher, J. B., Edgren, B. E., Mammel, M. C., & Coleman, J. M. (1985) · PubMed · Cited by 67
Paroxetine withdrawal syndrome in a neonate
Dahl, M. L., Olhager, E., & Ahlner, J. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.4.391c · Cited by 67
Suspected congenital sertraline dependence
Kent, L., & Laidlaw, J. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.3.412b · Cited by 64
Cited by
Moses-Kolko, E. L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B., & Wisner, K. L. (2005) · JAMA · doi:10.1001/jama.293.19.2372 · Cited by 533
Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
Wisner, K. L., Sit, D. K. Y., Hanusa, B. H., Moses-Kolko, E. L., Bogen, D. L., Hunker, D. F., Perel, J. M., Jones-Ivy, S., Bodnar, L. M., & Singer, L. T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081170 · Cited by 400
Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., & Klinger, G. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.2.173 · Cited by 329
Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry
Maciag, D., Simpson, K. L., Coppinger, D., Lu, Y., Wang, Y., Lin, R. C. S., & Paul, I. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300823 · Cited by 302
Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior
Zeskind, P. S., & Stephens, L. E. (2004) · Pediatrics · doi:10.1542/peds.113.2.368 · Cited by 280
Newport, D. J., Calamaras, M. R., DeVane, C. L., Donovan, J., Beach, A. J., Winn, S., Knight, B. T., Gibson, B. B., Viguera, A. C., Owens, M. J., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111886 · Cited by 257
Self-citationGender differences in depression and response to psychotropic medication
Gorman, J. M. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80199-3 · Cited by 195
Lattimore, K. A., Donn, S. M., Kaciroti, N., Kemper, A. R., Neal, C. R., & Vazquez, D. M. (2005) · Journal of Perinatology · doi:10.1038/sj.jp.7211352 · Cited by 189
“Placental passage of antidepressants has also been documented in humans.(21,22) One study compared maternal serum concentrations of SSRIs to infant umbilical vein serum concentrations at birth.”
BackgroundPrenatal SSRI use and offspring with autism spectrum disorder or developmental delay
Harrington, R. A., Lee, L.-C., Crum, R. M., Zimmerman, A. W., & Hertz-Picciotto, I. (2014) · Pediatrics · doi:10.1542/peds.2013-3406 · Cited by 174
Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors
Suri, D., Teixeira, C. M., Cagliostro, M. K. C., Mahadevia, D., & Ansorge, M. S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.231 · Cited by 167
Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
Lund, N., Pedersen, L. H., & Henriksen, T. B. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.164 · Cited by 153
“Selective serotonin reuptake inhibitors have been shown to readily cross the placenta and to be present in umbilical cord blood of exposed neonates.(20,21) Several case reports and case series have described a neonatal withdrawal symptom after in utero exposure to SSRIs.”
BackgroundGao, S.-Y., Wu, Q.-J., Sun, C., Zhang, T.-N., Shen, Z.-Q., Liu, C.-X., Gong, T.-T., Xu, X., Ji, C., Huang, D.-H., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1193-5 · Cited by 152
Antidepressants in pregnancy: a systematic review.
(2010) · PubMed · doi:10.3109/00048674.2010.507543 · Cited by 128
“Variable cord blood-to-maternal serum ratios have been found for both tricyclic depressants (TCAs) [15] and selective serotonin reuptake inhibitors (SSRIs) [10,11,13].”
BackgroundCortisol and anxiety response to a relaxing intervention on pregnant women awaiting amniocentesis
Ventura, T., Gomes, M. C., & Carreira, T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.05.016 · Cited by 107
Tuccori, M., Testi, A., Antonioli, L., Fornai, M., Montagnani, S., Ghisu, N., Colucci, R., Corona, T., Blandizzi, C., & Tacca, M. D. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.07.009 · Cited by 95
Pregnancy massage reduces prematurity, low birthweight and postpartum depression
Field, T., Diego, M., Hernandez-Reif, M., Deeds, O., & Figueiredo, B. (2009) · Infant Behavior and Development · doi:10.1016/j.infbeh.2009.07.001 · Cited by 87
New insights into how serotonin selective reuptake inhibitors shape the developing brain
Gingrich, J. A., Malm, H., Ansorge, M. S., Brown, A., Sourander, A., Suri, D., Teixeira, C. M., Caffrey Cagliostro, M. K., Mahadevia, D., & Weissman, M. M. (2017) · Birth Defects Research · doi:10.1002/bdr2.1085 · Cited by 53
Viktorin, A., Uher, R., Kolevzon, A., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1727 · Cited by 45
Prenatal SSRI exposure: Effects on later child development
Hermansen, T. K., & Melinder, A. (2015) · Child Neuropsychology · doi:10.1080/09297049.2014.942727 · Cited by 38
Metadata
- Authors
- Hendrick, V., Stowe, Z. N., Altshuler, L. L., Hwang, S., Lee, E., & Haynes, D.
- Venue
- American Journal of Psychiatry
- Published
- 2003-05-01
- Volume
- 160
- Issue
- 5
- Pages
- 993-996
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2101143167
- Cited by
- 380
- References
- 11
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.